This chapter details the epidemiology, route of spread, symptoms and prevalence, relating to viral infections acquired while abroad (HBV, HAV, HEV, HIV, noroviruses, dengue fever, arboviruses, haemorrhagic fever viruses, rabies).

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to measles virus. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to human parvovirus B19. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread and prevalence of viruses causing ’the common cold’ (coronaviruses, parainfluenzaviruses, rhinoviruses). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to poxviruses (smallpox, monkeypox, cowpox, molluscum contagiosum). It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to mumps virus. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter provides details of the viruses associated with maculopapular, vesicular and haemorrhagic skin rashes (parvovirus, rubellavirus, measlesvirus, enteroviruses, adenoviruses, HHV6, HHV7 , HSV, VZV, poxviruses , monkeypox and molluscum contagiosum). It gives details of symptoms, diagnosis and treatment.

This chapter details the epidemiology, route of spread, symptoms, diagnosis, treatment, prophylaxis and infection control relating to viruses causing hepatitis (HAV, HBV, HCV, HDV, HEV, CMV, EBV and arboviruses).

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to human adenoviruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter provides details of serological tests which can be used to detect viral antibodies or antigens in serum, saliva or urine (e.g. ELISA, EIA, IF, CFT, HAI, neutralisation, Western blot, line immunoassays and avidity tests). It details the utility of each test.

This chapter provides an overview of the antiviral drugs currently available, including maraviroc, aciclovir, penciclovir, ganciclovir, amantadine, zydovudine, adefovir, ribavirin, indinavir , oseltamivir, zanamivir, interferon alpha, rituximab , palivizumab, cidofovir, brincidofovir, foscarnet, remdesivir and paxlovid with an indication of their modes of action for treating virus infections, including HIV, herpes viruses, respiratory viruses, HBV, HCV, CMV, adenoviruses , BK, EBV (especially for PTLD), RSV, poxviruses and SARS-CoV-2.

This chapter deals with Occupational Health and how to protect healthcare workers from acquiring infections (e.g. HAV, HBV, HIV, HCV, VZV, influenza, Covid-19, measles, mumps, rubella, polio, TB, diphtheria, meningococcal infection and tetanus) while at work. It describes how healthcare workers can be protected by providing pre-exposure vaccinations and post-exposure treatments, as well as discussing responses to outbreaks and routes of infection.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to EBV. It provides information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to hepatitis B and D viruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the eye diseases (conjunctivitis, keratitis, retinitis and scleritis) caused by viruses and other organisms (adenoviruses, enteroviruses, HSV, measlesvirus, influenzaviruses, VZV, CMV, Toxoplasma gondii, molluscum contagiosum, papillomaviruses and HHV8). It details symptoms, epidemiology, diagnosis and treatment.

This chapter details the epidemiology, route of spread, prevalence, incubation period and at-risk groups relating to rhinoviruses. It gives information on symptoms, laboratory diagnosis, treatment, prophylaxis and infection control.

This chapter details the symptoms relating to the organisms which cause encephalitis and meningitis (HSV, VZV, enteroviruses, mumps virus). It gives information on laboratory diagnosis and treatment.